Archives

WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing

B Company is among the first in China’s drug-device combination products sector to obtain this certification, delivering superior solutions to global clients Zero non-conformities demonstrates company’s robust quality management system…

Read MoreWuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing

Agreement on Strategic Partnership Through Investment in U.S.-Based CargoSense, Expanding into the Data Center and Supply Chain Sectors Amid Growing Demand for AI Infrastructure

B RESTON, Va., April 14, 2026 /PRNewswire/ — CargoSense, Inc. (Headquarters: Virginia, USA; CEO: Richard Kilmer; hereinafter “CargoSense”), the provider of the world’s first “Agentic (Autonomous) Supply Chain Execution Platform,”…

Read MoreAgreement on Strategic Partnership Through Investment in U.S.-Based CargoSense, Expanding into the Data Center and Supply Chain Sectors Amid Growing Demand for AI Infrastructure